Detection of coronary artery disease by iodine-123-labeled iodophenyl-9- methyl pentadecanoic acid SPECT: Comparison with thallium-201 and iodine-123 BMIPP SPECT

Annals of Nuclear Medicine

Volumn 14, Issue 1, 2000, Pages 11-16

  Fukuchi, Kazuki ^b   Hasegawa, Shinji ^b   Ito, Yasushi ^b   Yamaguchi, Hitoshi ^b   Yoshioka, Jun ^b   Uehara, Toshiisa ^b   Nishimura, Tsunehiko ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b NONE

Author keywords

Coronary artery disease; Iodine 123 BMIPP; Iodine 123 iodophenyl 9 methyl pentadecanoic acid; Thallium 201

Indexed keywords

15 (4 IODOPHENYL) 3 METHYLPENTADECANOIC ACID I 123; DECANOIC ACID DERIVATIVE; IODOPHENYL 9 METHYLPENTADECANOIC ACID I 123; THALLIUM 201; UNCLASSIFIED DRUG;

ADULT; AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; EXERCISE TEST; FATTY ACID METABOLISM; FEMALE; HEART INFARCTION; HUMAN; MALE; PRIORITY JOURNAL; SCORING SYSTEM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0034084985     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02990473     Document Type: Article

References (16)

1. Machulla HJ, Marsmann M, Dutschka K. Biochemical concept and synthesis of a radioiodinated phenyl fatty acid for in vivo metabolic studies of the myocardium. Eur J Nucl Med 5: 171-173, 1980.
2. Miller DD, Gill JB, Livni E, Elmaleh DR, Aretz T, Boucher CA, et al. Fatty acid analogue accumulation: a marker of myocyte viability in ischemic-reperfused myocardium. Circ Res 63: 681-692, 1988.
3. Knapp FF Jr. Myocardial metabolism of radioiodinated BMIPP. J Nucl Med 36: 1051-1054, 1995.
4. Knapp FF Jr, Franken P, Kropp J. Cardiac SPECT with iodine-123-labeled fatty acids: evaluation of myocardial viability with BMIPP. J Nucl Med 36: 1022-1030, 1995.
5. 123[-beta-methyl-iodo-phenyl pentadecanoic acid. Eur J Nucl Med 21: 283-291, 1994.
6. 99mTc-sestamibi. Ann Nucl Med 9: 125-130, 1995.
7. Franken PR, Dendale P, De Geeter F, Demoor D, Bossuyt A, Block P. Prediction of functional outcome after myocardial infarction using BMIPP and sestamibi scintigraphy. J Nucl Med 37: 718-722, 1996.
8. Tateno M, Tamaki N, Yukihiro M, Kudoh T, Hattori N, Tadamura E, et al. Assessment of fatty acid uptake in ischemic heart disease without myocardial infarction. J Nucl Med 37: 1981-1985, 1996.
9. Miller DD, Barlai-Kovach M, Gill JB. Imaging characteristics of a new single-photon myocardial metabolic tracer. Circulation 74: II-62, 1986.
10. Knapp FF Jr, Ambrose KR, Goodman MM. New radioiodinated methyl-branched fatty acids for cardiac studies. Eur-J Nucl Med 12: S39-S44, 1986.
11. Chouraqui P, Maddahi J, Henkin R, Karesh SM, Galie E, Berman DS. Comparison of myocardial imaging with iodine-123-iodophenyl-9-methyl pentadecanoic acid and thallium-201-chloride for assessment of patients with exercise-induced myocardial ischemia. J Nucl Med 32: 447-452, 1991.
12. 123I-labelled 9-methyl-branched pentadecanoic acid (9MPA) using SPET. Nucl Med Commun 19: 839-847, 1998.
13. Bax JJ, Wijns W, Cornel JH, Visser FC, Boersma E, Fioretti PM. Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: comparison of pooled data. J Am Coll Cardiol 30: 1451-1460, 1997.
14. 121I-BMIPP in patients with stable effort angina pectoris. Nucl Med Commun 16: 1002-1008, 1995.
15. Tamaki N, Kawamoto M, Yonekura Y, Fujibayashi Y, Takahashi N, Konishi J, et al. Regional metabolic abnormality in relation to perfusion and wall motion in patients with myocardial infarction: assessment with emission tomography using an iodinated branched fatty acid analog. J Nucl Med 33: 659-667, 1992.
16. Tamaki N, Kawamoto M, Yonekura Y, Fujibayashi Y, Magata Y, Torizuka T, et al. Assessment of fatty acid metabolism using I-123 branched fatty acid: comparison with positron emission tomography. Ann Nucl Med 7 (Suppl II): SII-41-SII-47, 1993.